Lv3
276 积分 2025-03-13 加入
Alternative Strategies for Toxicity Testing of Species-Specific Biopharmaceuticals
1个月前
已完结
Selective Targeting of STAT6: Recent Advances and Future Perspectives
1个月前
已完结
KIF18A inhibition and its rising role in cancer therapy trials: from bench to bedside
5个月前
已完结
The role of JAK/STAT signaling pathway and its inhibitors in diseases
7个月前
已完结
Regulatory and Scientific Issues Regarding Use of Foreign Data in Support of New Drug Applications in the United States: An FDA Perspective
7个月前
已完结
A therapeutic algorithm guiding subsequent therapy selection after CDK4/6 inhibitors’ failure: a review of current and investigational treatment for HR+/Her2- breast cancer
10个月前
已完结
Radiolabeled Absorption, Distribution, Metabolism, and Excretion Studies in Drug Development: Why, When, and How?
11个月前
已完结
Mass Balance Studies in Animals and Humans
11个月前
已完结
Novel endocrine therapies: What is next in estrogen receptor positive, HER2 negative breast cancer?
11个月前
已完结
皖公网安备34019202002308
